Emphysema Global Clinical Trials Review, H2, 2017

2017-08-11
Price :
Published : Aug-2017
No. of Pages : 80
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Emphysema to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Emphysema to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Emphysema Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Emphysema 32
May 08, 2017: Prometic to Present New Data on PBI-4425 at the American Thoracic Society's 2017 International Conference 32
Clinical Trial Profile Snapshots 33
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Source 80

List of Tables
Emphysema Therapeutics, Global, Clinical Trials by Region, 2017* 7
Emphysema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Emphysema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Emphysema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Emphysema Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Emphysema Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Emphysema Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Emphysema Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Emphysema to Respiratory Clinical Trials, G7 Countries (%), 2017* 15
Emphysema Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Emphysema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Emphysema to Respiratory Clinical Trials, E7 Countries (%), 2017* 18
Emphysema Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Emphysema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Emphysema Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Emphysema Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Emphysema Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Emphysema Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Emphysema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Emphysema Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Emphysema Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Emphysema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Emphysema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures
Emphysema Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Emphysema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Emphysema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Emphysema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Emphysema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Emphysema Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Emphysema Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Emphysema Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Emphysema to Respiratory Clinical Trials, G7 Countries (%), 2017* 15
Emphysema Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Emphysema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Emphysema to Respiratory Clinical Trials, E7 Countries (%), 2017* 18
Emphysema Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Emphysema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Emphysema Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Emphysema Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Emphysema Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Emphysema Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Emphysema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Emphysema Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Emphysema Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Emphysema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Emphysema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
GlobalData Methodology 79
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData